Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells. [electronic resource]
Producer: 20141114Description: 115-22 p. digitalISSN:- 1000-467X
- Antineoplastic Agents, Alkylating -- pharmacology
- Cell Line, Tumor
- Dacarbazine -- analogs & derivatives
- Drug Resistance, Neoplasm
- Drug Synergism
- Glioma -- metabolism
- Humans
- Leupeptins -- pharmacology
- NF-kappa B -- antagonists & inhibitors
- Neoplastic Stem Cells -- metabolism
- O(6)-Methylguanine-DNA Methyltransferase -- metabolism
- Temozolomide
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.